- Recent Funding
- Investors
- Regents of The University of Minnesota
Regents of The University of Minnesota portfolio
Regents of The University of Minnesota has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Totus Medicines's $66M Series B+ round in December 2023, alongside DCVC Bio, Camford Capital and Northpond Ventures. That company is in Health and bio.
What Regents of The University of Minnesota invests in
- Health and bio · 1 · 100%
How Regents of The University of Minnesota invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $66M |
Regents of The University of Minnesota portfolio companies
TTotus Medicines$66MSeries B+ · Dec 2023
| Company | Round with Regents of The University of Minnesota | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $66M | $106M | Dec 17, 2023 Series B+ |
Most frequent co-investors
NNorthpond Ventures1 shared round · last Dec 17, 2023
DDCVC Bio1 shared round · last Dec 17, 2023
CCamford Capital1 shared round · last Dec 17, 2023
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Regents of The University of Minnesota. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Regents of The University of Minnesota, which is a subset of its real portfolio. API: /api/v1/investors/regents-of-the-university-of-minnesota (get a free API key). More: the most active VC firms and new venture capital funds.